• Scientific rationale

    Thanks to the participation of a panel of nationally and internationally renowned speakers, the meeting aims to:

    • Expanding participants’ knowledge about clinical indications and advantages of hadrontherapy in an international overview and perspectives
    • Informing participants on managerial, technical and clinical aspect of an hadrontherapy facility 
    • Improving understanding on resource requirements, challenges, economical and social implications of hadrontherapy
    • Presenting status and perspectives of a new research clinical modality, BNCT (Boron Neutron Capture Therapy)

    Learning materials

    Learning materials related to this course will be available in this section after the end of the activity and for the following 30 days.
    Learning materials - as well as video recordings of the course, if available - will be accessible only to those participants who have attended the course.
    Only materials authorized for distribution by their authors are made available through this platform.

    LEARNING MATERIALS IN-CLASS COURSE - 11 and 12 October   LEARNING MATERIALS DIGITAL EVENT - 11 and 12 October LEARNING MATERIALS IN-CLASS COURSE - 13 October   LEARNING MATERIALS DIGITAL EVENT - 13 October

  • Programme

    09:00Participant Registration
    09:30Welcome Addresses

    SESSION 1: CLINICAL ACTIVITIES
    		Moderatore: Lisa Francesca Linda Licitra
    09:45Keynote lecture Historical and scientific evolution of hadrontherapy
    		Ugo Amaldi
    10:15Hadrontherapy in the context of cancer care in Italy
    		Marco Krengli
    10:35Hadrontherapy vs X-ray therapy: clinical aspects, patient pathway and clinical QA considerations

    Clinical indications:
    		Ester Orlandi
    10:55Chordoma and Chondrosarcoma 
    		Piero Fossati
    11:15Coffee Break
    11:30Head and Neck cancers
    		Barbara Vischioni
    11:50Central Nervous System tumors
    		Semi Harrabi
    12:10Gastroenteric and gynaecological tumors
    		Amelia Barcellini
    12:30Pediatric cancers 
    		Sabina Vennarini
    12:50Heavy ions for prostate cancer: how to manage pelvic nodes?
    		Mack Roach
    13:10Lunch
    SESSION 2: CLINICAL ACTIVITIES
    		Moderatore: Mario Ciocca
    14:30Clinical research and future prospective
    		Roberto Orecchia
    14:50Patient clinical workflow including image guidance
    		Guido Baroni
    15:10Treatment planning: comparing techniques and standards
    		Silvia Molinelli
    15:30Clinical dosimetry and quality assurance
    		Stefano Lorentini
    15:50Coffee Break
    16:05Radiobiology: current trend and future prospective
    		Micheal Story
    16:25Novel approaches in particle therapy
    		Andrea Mairani
    16:45Implementing a carbon ion facility: the Mayo Clinic ProjectLaura Vallow
    19:30Social Event
    SESSION 3: HEALTH POLICY CONTEXT AND HEALTH ECONOMICS OF HADRON THERAPY
    		Moderatore: Andrea Riccardo Filippi
    09:00ENLIGHT (European  Network for  Light Ion  Hadron Therapy)  and  its  role  in  Hadron Therapy
    		Manjit Dosanjh
    09:20Academia meets Industry: IP, communication, managing expectations
    		Manuela Cirilli
    09:40Funding and health economic
    		Fabio Michele Amatucci
    10:00Financial toxicity: PSI experience
    		Barbara Bachtiary
    10:20CNAO: cost benefit Analysis
    		Maria Vittoria Livraga
    10:40Coffee Break
    SESSION 4: ORGANIZATION AND OPERATION OF MULTI PARTICLE THERAPY FACILITY
    		Moderatore: Marco Cianchetti
    11:00The Heidelberg Ion Beam Therapy Center - Technology, Clinical Application and Research
    		Thomas Haberer
    11:20The CNAO facility: operation and maintenance
    		Giuseppe Venchi
    11:40The MedAustron facility
    		Mauro Torino Francesco Pivi
    12:00The Marburg facility
    		Klemens Zink
    12:20New accelerator designs: NIMMS
    		Maurizio Vretenar
    12:40The vision of the SEEIIST project 
    		Leander Litov
    13:00Carbon facilities outside Europe with focus on USA/NCI programme
    		Arnold Pompos
    13:20Lunch
    SESSION 5: RESEARCH & DEVELOPMENT IN HADRONTHERAPY
    		Moderatore: Giuseppe Antonio Pablo Cirrone
    14:30Building capacity through the IAEA programs
    		Sotirios Charisopoulos
    14:50HITRIplus project overview
    		Angelica Facoetti
    15:10Imaging: current trends and future perspectives
    		Katia Parodi
    15:30Flash Therapy with light ions
    		Emanuele Scifoni
    15:50Coffee Break
    16:05Upright positioning and arc therapy
    		Christian Graeff
    16:25New Gantry for ions
    		Marco Giuseppe Pullia
    16:45New technologies: superconducting magnets
    		Ernesto De Matteis
    17:05Discussion
    17:30Visit of CNAO
    BNCT: SESSION 1
    Chair: Saverio Altieri – Paolo Pedrazzoli
    09:00Hadron therapy in radiation oncology and why BNCT is a paradigm shift
    		Wolfgang Sauerwein
    09:20Clinical BNCT experience with accelerators
    		Minoru Suzuki
    09:40BNCT clinical trials
    		Peeter Karihtala
    10:00Progress to clinical adoption of accelerator based BNCT
    		Lisa Licitra
    10:20Development of new novel BNCT drugs
    		Kendall Morrison
    10:40Online boron dose distribution imaging
    		Nicoletta Protti
    11:00Coffee break
    BNCT: SESSION 2
    Chair: Valerio Vercesi – Barbara Croesi
    11:20Radiobiological characterization of a BNCT beam
    		Mitsuko Masutani
    11:40Dosimetry in BNCT
    		Stuart Green
    12:00Micro-dosimetry of a neutron BNCT beam
    		Valeria Conte
    12:20Treatment planning for BNCT
    		Ian Postuma
    12:40Discussion
    13:00Lunch
    BNCT: SESSION 3
    Chair: Stefano Agosteo – Laura Locati
    14:00Structural basis of cancer cells uptake of boronated compounds
    		Vittorio Bellotti
    14:20Accelerator based neutron sources for BNCT
    		Andres Kreiner
    14:40Development of the IAEA publication ‘Advances in Boron Neutron Capture Therapy
    		Ian Swainson
    15:00BNCT@CNAO
    		Sandro Rossi
    15:20Discussion and closing remarks
    15:40Visit of LENA